Offer - Urjas Oil for just ₹ 1 X
Pegmove Powder for Oral Solution is a commercial drug that is prescribed in the form of Powder. Primarily, it is used for the treatment of Constipation.
The optimal dosage of Pegmove Powder for Oral Solution is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Pegmove Powder for Oral Solution can also lead to other problems, which have been listed below. These side effects of Pegmove Powder for Oral Solution are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Pegmove Powder for Oral Solution's effect during pregnancy is Moderate and Moderate while nursing. It is important to know if Pegmove Powder for Oral Solution has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Pegmove Powder for Oral Solution related warnings section.
Some other conditions that can be affected by Pegmove Powder for Oral Solution are listed in the contraindications section below.
Drug reaction of Pegmove Powder for Oral Solution with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Pegmove Powder for Oral Solution is considered not safe while driving, and is not addictive.
Pegmove Powder for Oral Solution is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Pegmove Powder for Oral Solution safe for pregnant women?
Pregnant women may experience moderate side effects from Pegmove. It is best to stop taking Pegmove immediately and inform your doctor if you notice any discomfort.
Is the use of Pegmove Powder for Oral Solution safe during breastfeeding?
Pegmove may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Pegmove, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Pegmove.
What is the effect of Pegmove Powder for Oral Solution on the Kidneys?
Pegmove rarely harms the kidneys.
What is the effect of Pegmove Powder for Oral Solution on the Liver?
Using Pegmove does not have any harmful effects on the liver.
What is the effect of Pegmove Powder for Oral Solution on the Heart?
You can take Pegmove without any fear of damage to the heart.
If you are suffering from any of the following diseases, you should not take Pegmove Powder for Oral Solution unless your doctor advises you to do so -
Is this Pegmove Powder for Oral Solution habit forming or addictive?
No, there is no any evidence that Pegmove Powder for Oral Solution is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Pegmove Powder for Oral Solution can make you feel drowsy.
Is it safe?
Yes, but take Pegmove Powder for Oral Solution only as per medical advice.
Is it able to treat mental disorders?
No, the use of Pegmove Powder for Oral Solution in mental disorders is not effective.
Interaction between Food and Pegmove Powder for Oral Solution
There is no information on the effects of taking Pegmove Powder for Oral Solution with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Pegmove Powder for Oral Solution
Due to lack of research, there is no information about the side effects of taking Pegmove Powder for Oral Solution with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Polyethylene Glycol 3350
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1036